Patent · US Expired

2-[2H-(1,3-dihydroisoindole)alkylene]-4,5-dihydroimidazoles and pharmaceutical compositions thereof

US4863946A · kind A · utility

1Cited by
1References
14Claims
0Family size

Assignee

Inventor

Key dates

Filing dateDec 1, 1986
Grant dateSep 5, 1989
Priority date
Expiry dateDec 1, 2006

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/06
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A compound of formula (I): ##STR1## or a pharmaceutically acceptable salt, ester or amide thereof, wherein: Z represents a residue of a substituted or unsubstituted aryl group, PA0 X represents O or NR.sup.o wherein R.sup.o represents a hydrogen atom, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, an alkanoyl group substituted or unsubstituted in the alkyl moiety, or an arylalkyl moiety substituted or unsubstituted in the aryl moiety. PA0 n represents an integer 1 or 2, PA0 m represents an integer 1 or 2, PA0 p represents an integer 2 or 3, and PA0 q represents an integer in the range of from 1 to 12; pharmaceutical compositions containing such compounds and the use of such compounds and compositions in medicine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.